IL153059A0 - Heparanase mediated cell adhesion and uses thereof - Google Patents
Heparanase mediated cell adhesion and uses thereofInfo
- Publication number
- IL153059A0 IL153059A0 IL15305902A IL15305902A IL153059A0 IL 153059 A0 IL153059 A0 IL 153059A0 IL 15305902 A IL15305902 A IL 15305902A IL 15305902 A IL15305902 A IL 15305902A IL 153059 A0 IL153059 A0 IL 153059A0
- Authority
- IL
- Israel
- Prior art keywords
- cell adhesion
- mediated cell
- heparanase mediated
- heparanase
- adhesion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01166—Heparanase (3.2.1.166)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15305902A IL153059A0 (en) | 2002-11-24 | 2002-11-24 | Heparanase mediated cell adhesion and uses thereof |
AU2003282363A AU2003282363A1 (en) | 2002-11-24 | 2003-11-24 | Heparanase mediated cell adhesion and uses thereof |
PCT/IL2003/000989 WO2004048558A2 (en) | 2002-11-24 | 2003-11-24 | Heparanase mediated cell adhesion and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15305902A IL153059A0 (en) | 2002-11-24 | 2002-11-24 | Heparanase mediated cell adhesion and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL153059A0 true IL153059A0 (en) | 2003-06-24 |
Family
ID=30011950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15305902A IL153059A0 (en) | 2002-11-24 | 2002-11-24 | Heparanase mediated cell adhesion and uses thereof |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2003282363A1 (en) |
IL (1) | IL153059A0 (en) |
WO (1) | WO2004048558A2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR927003090A (en) * | 1989-08-23 | 1992-12-17 | 하다사 메디칼 오르가니제이션 | Wound Healing Agents Including Heparin Enzyme |
US20010006630A1 (en) * | 1997-09-02 | 2001-07-05 | Oron Yacoby-Zeevi | Introducing a biological material into a patient |
-
2002
- 2002-11-24 IL IL15305902A patent/IL153059A0/en unknown
-
2003
- 2003-11-24 WO PCT/IL2003/000989 patent/WO2004048558A2/en not_active Application Discontinuation
- 2003-11-24 AU AU2003282363A patent/AU2003282363A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004048558A2 (en) | 2004-06-10 |
AU2003282363A8 (en) | 2004-06-18 |
WO2004048558A3 (en) | 2004-07-22 |
AU2003282363A1 (en) | 2004-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1539941A4 (en) | Adzymes and uses thereof | |
AU2003217350A1 (en) | Proliferated cell lines and uses thereof | |
EP1547451A4 (en) | Cell adhesion resisting surfaces | |
EP1519431A4 (en) | Electrode and cell comprising the same | |
IL166377A0 (en) | Vrgfr-2 and vgefr-3 inhibitory and anthranylamidpyrimidines | |
AU2003249350A1 (en) | Electrochemiluminescence flow cell and flow cell components | |
HU0301063D0 (en) | Benzoic-acid isononylesters and applying them | |
AU2003278770A8 (en) | Electrochemical cells and systems | |
AU2003246262A1 (en) | Novel polyimide copolymer and metal laminate comprising the same | |
IL165112A0 (en) | Variant integrinpolypeptides and thereof | |
AU2003292720A8 (en) | Dihydrothienoquinoline derivatives and cell adhesion inhibitors containing the same | |
AU2003239891A1 (en) | Primer composition and bonded structure | |
AU2003231827A8 (en) | Pseudo-tissues and uses thereof | |
AU2003228355A1 (en) | Adipocytes and uses thereof | |
AU2002319895A1 (en) | Improved in scaffold connections | |
AU2003262744A8 (en) | Alpha-amylase assay and uses thereof | |
GB0228525D0 (en) | Polymers and their use | |
AU2003282363A8 (en) | Heparanase mediated cell adhesion and uses thereof | |
AU2003302173A8 (en) | Spirotetrathiocarbamates and spirooxothiocarbamates | |
AU2003300396A1 (en) | Chemokine antagonists and uses thereof | |
AU2003220265A1 (en) | Tamperproof and counterfeit-resistant structure | |
AU2003230671A1 (en) | Improvements in electrochemistry | |
GB2385592B (en) | Composition comprising an N-acyl taurate, or N-acyl taurine, and 8-hydroxyquinaldine | |
GB0207624D0 (en) | Chemokine and uses thereof | |
AU2003216442A8 (en) | Enkurin and uses thereof |